Filing Flows › Companies › Agilent Technologies › Analysis traps
Agilent Technologies (A): analysis traps
Where its figures could mislead a reader, and what to check before taking them at face value · Data: Q3 FY26, to Jul 31, 2026, filed Sep 1, 2026; rules v1.1
Agilent Technologies (A): 1 rule of 10 triggered on the filings to Jul 31, 2026: adjusted profit = economic profit. 1 to review; 1 with insufficient data; 2 not applicable. Each is a question to verify, with the normal explanation that would produce the same figures.
Check these first
Adjusted profit = economic profit Triggered · severity medium · confidence low
Adjusted EPS was at least 10% above GAAP in 3 of the last 3 quarters (on average 21% above). Costs excluded every quarter (restructuring, stock compensation, amortisation of acquired intangibles, litigation) are a recurring cost of the business, not a one-off.
Innocent reading: A genuine one-off this year (an impairment, a settlement) that happens to span several quarters.
A precise DCF value = the true value To review · confidence high
The DCF's point value is 69.88 a share (price 174.76); 72% of it is the terminal value, a number about years no one has seen. Moving revenue growth (each year) by ±5 pts alone takes it from 55.59 to 86.91; across every method the research ran the range is 23 to 228. The value is a range; the decimals are not information.
Innocent reading: A stable, mature business with a narrow range of outcomes, where the point value is a fair summary.
Every rule
A01 FCF growth = the business improved Not triggered confidence high
Free cash flow did not rise ($1.4B → $1.2B): the trap does not arise.
The figures and how they are read
| Fiscal year before | FY24 |
| Fiscal year | FY25 |
| Operating cash flow, year before | $1.8B |
| Operating cash flow | $1.6B |
| Capex, year before | $378M |
| Capex | $407M |
| Free cash flow, year before | $1.4B |
| Free cash flow | $1.2B |
| Change in FCF | −$221M |
| Change in capex | $29M |
| Working capital: change in its cash contribution | −$119M |
FCF = operating cash flow − cash capex; ΔFCF = ΔOCF − ΔCapEx; the working-capital part is the change in the cash-bridge items (receivables, inventory, payables, accruals), with the sign of the cash flow statement
Source: FY25 (cash flow statement, fiscal year) · FY24 (cash flow statement, fiscal year before)
A07 Stock compensation added back = no economic cost Not triggered confidence high
Stock compensation is 1.8% of revenue: small enough that adding it back changes little.
The figures and how they are read
| Fiscal year | FY25 |
| Stock compensation | $128M |
| Revenue | $6.9B |
| SBC / revenue | +1.8% |
| Buybacks | $425M |
| Buybacks / SBC | 3.3 |
| Diluted shares, year before | 291.0M shares |
| Diluted shares | 285.0M shares |
| Diluted shares: change | -2.1% |
SBC / revenue from the cash flow statement's add-back; the diluted weighted share count year over year; buybacks from the financing section
Source: FY25 (stock compensation, buybacks and the diluted share count, fiscal year)
B02 Receivables growing = future cash is certain Not triggered confidence medium
Receivables grew 7% against revenue 8% in Q3 FY26; DSO 73 against a median of 73: collections are keeping pace with sales.
The figures and how they are read
| Quarter | Q3 FY26 |
| Revenue, year over year | +8.1% |
| Receivables, year over year | +7.0% |
| Quarter before | Q2 FY26 |
| Revenue y/y, quarter before | +10.0% |
| Receivables y/y, quarter before | +9.7% |
| Days sales outstanding | 72.9 |
| DSO, median of eight quarters | 72.6 |
| Receivables | $1.5B |
| Revenue | $1.9B |
receivables and revenue against the same quarter a year earlier; DSO = receivables / quarterly revenue × days, against the median of the eight quarters before
Source: Q3 FY26 (receivables and revenue) · Q3 FY25 (the same quarter a year earlier)
B08 Adjusted profit = economic profit Triggered severity medium · confidence low
Adjusted EPS was at least 10% above GAAP in 3 of the last 3 quarters (on average 21% above). Costs excluded every quarter (restructuring, stock compensation, amortisation of acquired intangibles, litigation) are a recurring cost of the business, not a one-off.
The figures and how they are read
| Quarter / adjusted EPS / GAAP EPS / gap | 2026-01-31 / 1.36 / 1.07 / 0.213; 2026-04-30 / 1.49 / 1.2 / 0.195; 2026-07-31 / 1.62 / 1.28 / 0.21 |
| Quarters with adjusted ≥ 10% above GAAP | 3 |
| Quarters compared | 3 |
| Latest gap | +21.0% |
the analysts' 'actual' (usually the company's adjusted EPS) against GAAP net income ÷ diluted shares for the matching quarter; a gap of 10% or more counts (the stand-in until three releases' reconciliation tables are on file)
Source: 2026-01-31 (adjusted 1.36 vs GAAP 1.07) · 2026-04-30 (adjusted 1.49 vs GAAP 1.20) · 2026-07-31 (adjusted 1.62 vs GAAP 1.28)
What would explain it innocently
- A genuine one-off this year (an impairment, a settlement) that happens to span several quarters
- Amortisation of acquired intangibles, which many investors also exclude by choice
- The analysts' 'actual' is not the company's own adjusted figure
What to look for in the filing
- The reconciliation table in the earnings release: which items, how much, how often
- Whether the same items were excluded in earlier years
What would show the trap does not apply
- The reconciliation shows the excluded items ending (a restructuring with its final charge, a settlement paid) and the gap to GAAP closes in the next quarters
- The excluded items are only amortisation of acquired intangibles and the cash paid for the deals is in the investing cash flow
Look again: next filing.
C02 Low net debt = no refinancing risk Insufficient data
neither a maturity table nor the current portion of debt is on file
D03 EPS growth = profit growth Not triggered confidence high
EPS rose 8% and net income rose 8% in Q3 FY26; the share count fell 0.7%: EPS growth follows profit growth.
The figures and how they are read
| Quarter | Q3 FY26 |
| Quarter before | Q3 FY25 |
| EPS, year before | $1.18 |
| EPS | $1.28 |
| Net income, year before | $336M |
| Net income | $362M |
| Diluted shares, year before | 285.0M shares |
| Diluted shares | 283.0M shares |
| EPS growth | +8.5% |
| Net income growth | +7.7% |
| Diluted shares: change | -0.7% |
| eps from profit | $0.09 |
| eps from share count | $0.01 |
EPS and net income against the same quarter a year earlier; the EPS bridge attributes the change to profit first, then to the share count (the order is fixed and disclosed)
Source: Q3 FY26 (net income, diluted shares, EPS) · Q3 FY25 (the same quarter a year earlier)
E02 Low P/E at a cyclical peak = undervalued Not triggered confidence medium
Net income of $1.4B is not at a cyclical high against the last eight years (median $1.3B, best $1.3B): the P/E of 34.3× is on a normal year.
The figures and how they are read
| market value | $49.5B |
| net income ttm | $1.4B |
| pe ttm | 34.30 |
| net income median fy | $1.3B |
| pe mid cycle | 39.40 |
| net income peak fy | $1.3B |
| years | FY20 / 719.0; FY21 / 1210.0; FY22 / 1254.0; FY23 / 1240.0; FY24 / 1289.0; FY25 / 1303.0 |
| down years in window | 1 |
P/E on the trailing twelve months' net income against the P/E on the median net income of the last eight fiscal years (a mid-cycle stand-in); 'at a peak' = this year's profit at or above 90% of the best year and at least 1.3× the median
Source: Q3 FY26 (net income, trailing twelve months)
E07 A precise DCF value = the true value To review confidence high
The DCF's point value is 69.88 a share (price 174.76); 72% of it is the terminal value, a number about years no one has seen. Moving revenue growth (each year) by ±5 pts alone takes it from 55.59 to 86.91; across every method the research ran the range is 23 to 228. The value is a range; the decimals are not information.
The figures and how they are read
| dcf value | 69.88 |
| price | 174.76 |
| terminal value share | +71.6% |
| swing by input | Revenue growth (each year) / ±5 pts / 55.59 / 86.91; WACC / ±1 pt / 59.92 / 83.31; Operating margin / ±3 pts / 59.19 / 80.57; Tax rate / ±5 pts / 65.32 / 74.44 |
| range all methods | 22.99; 227.64 |
the DCF's point value against the share of it that is the terminal value and the value at each input moved by one step (growth ±5 pts, WACC ±1 pt, margin ±3 pts …); the range across every method the research ran
Source: 2026-11-08 (valuation research)
What would explain it innocently
- A stable, mature business with a narrow range of outcomes, where the point value is a fair summary
- The inputs that matter most are themselves well known (a regulated return, a long contract)
What to look for in the filing
- Which input you believe differs from the research's and why
- What the price implies for growth (the reverse DCF on the fair-value page)
What would show the trap does not apply
- The DCF's value is robust to the terminal growth and discount rate (the range's low end is still above the price)
- The company's cash flows over the next three years track the DCF's early years
Look again: next filing.
J06 A bank's low P/E and high profit = safe Not applicable
not a bank
J08 A REIT's low net income = the dividend is unsafe Not applicable
not a REIT
What the statuses mean
Triggered: the filings show the pattern; read the normal explanations and the missing evidence before concluding anything. To review: one quarter or a weak signal; a reader's judgement, not a pattern. Not triggered: the pattern is absent on these figures. Insufficient data: the filings read so far do not hold what the rule needs; this is not a clean bill. Not applicable: the rule is not meant for this kind of company (a bank's working capital, a loss-making quarter's EPS growth). Out of date: the latest filing is more than fifteen months old.
Severity is what the pattern could mean for cash, value or solvency; confidence is how reliable the inputs and the reading are. The two are kept apart.
Record a view
A reader's judgement, grounds, what would change it and the next review; kept in the browser (needs JavaScript).
Every rule and the companies it triggers on → Agilent Technologies: cash flow → Earnings quality score →
Each rule reads the company's own filings by a fixed formula and says what would explain the same figures innocently. A triggered rule is a question to verify, not a finding of manipulation, and not a view on the stock. Missing data is shown as missing, never as clear. Not investment advice.